Advertisement
News
Advertisement

InVivo Therapeutics raises $10.5M, completes reverse merger

Wed, 10/27/2010 - 10:33am
Mass High Tech: The Journal of New England Technology

InVivo Therapeutics Corp., a Cambridge spinal cord injury treatment developer, has completed a reverse merger and initiated a $10.5 million private placement offering.

The reverse merger was conducted with InVivo Therapeutics Holdings Corp., with the holding company operating InVivo Therapeutics as a wholly-owned subsidary and quoted on the Over-the-Counter market under the ticker symbol “NVIV.” InVivo Therapeutics’ current management team will retain their positions in the subsidiary. As part of the merger, 31.6 million shares of the holding company’s common stock were offered to InVivo Therapeutics shareholders.

SOURCE

Topics

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading